SuperworthMettler-Toledo International EPS MTD
Diluted earnings per share by quarter and over the last twelve months, from 2009.
- Last 12 months, to Jun 30, 2026
- $44.42
- Latest quarter, Q2 FY26
- $11.55
- +18% on a year earlier
- Fiscal year 2025
- $42.11
- +4% on the year before
Mettler-Toledo International's earnings per share was $44.42 over the twelve months to Jun 30, 2026, up 12% on a year earlier.
In its latest quarter, Q2 FY26, it was $11.55, up 18% on the same quarter a year before.
Over the five fiscal years to FY2025 it grew 11% a year on average.
Earnings per share over time
Fiscal year by fiscal year
| Fiscal year | EPS | Change |
|---|---|---|
| FY2025 | $42.11 | +4% |
| FY2024 | $40.53 | +13% |
| FY2023 | $35.89 | −7% |
| FY2022 | $38.46 | +17% |
| FY2021 | $32.82 | +31% |
| FY2020 | $24.96 | +11% |
| FY2019 | $22.52 | +13% |
| FY2018 | $19.93 | +40% |
| FY2017 | $14.24 | −0% |
| FY2016 | $14.27 | +14% |
| FY2015 | $12.52 | +9% |
| FY2014 | $11.48 | +15% |
| FY2013 | $9.99 | +9% |
| FY2012 | $9.18 | +12% |
| FY2011 | $8.23 | +21% |
Each fiscal year is the twelve months to its fourth quarter.
Quarter by quarter
| Quarter | Ended | EPS | On a year earlier | Last 12 months |
|---|---|---|---|---|
| Q2 FY26 | $11.55 | +18% | $44.42 | |
| Q1 FY26 | $8.33 | +7% | $42.63 | |
| Q4 FY25 | $13.97 | +17% | $42.11 | |
| Q3 FY25 | $10.57 | +6% | $40.10 | |
| Q2 FY25 | $9.76 | −6% | $39.49 | |
| Q1 FY25 | $7.81 | −5% | $40.10 | |
| Q4 FY24 | $11.96 | +40% | $40.53 | |
| Q3 FY24 | $9.96 | +8% | $37.09 | |
| Q2 FY24 | $10.37 | +7% | $36.34 | |
| Q1 FY24 | $8.24 | −3% | $35.66 | |
| Q4 FY23 | $8.52 | −28% | $35.89 | |
| Q3 FY23 | $9.21 | −6% | $39.23 |
Against its peers
Companies in Medical - Diagnostics & Research nearest Mettler-Toledo International's size, closest first, today.
| Company | EPS, 12 months | Growth |
|---|---|---|
| MTDMettler-Toledo International | $44.42 | +12% a year |
| ILMNIllumina | $5.38 | −32% a year |
| DGXQuest Diagnostics | $9.41 | +18% a year |
| LHLabcorp | $12.09 | +33% a year |
| IDXXIDEXX Laboratories | $14.22 | +18% a year |
| WATWaters | $4.01 | −64% a year |
| IQVIQVIA | $8.06 | +17% a year |
| AAgilent Technologies | $5.09 | +19% a year |
| MEDPMedpace | $17.05 | +27% a year |
| RVTYRevvity | $2.10 | −11% a year |
| BIOBio-Rad Laboratories | $8.25 | −30% a year |
| Peer median | $8.15 |
Where Mettler-Toledo International ranks
What the EPS figure tells you
Net income divided by diluted shares. The denominator of PE.
One-off charges and gains swing it. The TTM view smooths a single odd quarter.
More on Mettler-Toledo International
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.